International Association for the Study of Lung Cancer

09/05/2026

What should the future of AI in lung cancer care look like?

IASLC wants to hear from the people at the center of that conversation: patients and health professionals.

Two parallel surveys from the IASLC Artificial Intelligence Taskforce are exploring how patients and clinicians use and trust AI, the concerns they have and what they want to see in the future.

👤 Patients: Share your perspective on AI in cancer care.
🩺 Physicians and health professionals: Tell us about your experiences and priorities for AI in thoracic oncology.

Hearing from both groups will help us understand where perspectives align and where they differ.

Take the Patient Survey: https://bit.ly/3SFuvj1
Take the Physician & Health Professional Survey: https://bit.ly/4x2DqJF

09/04/2026

🧳 Heading to Seoul for ? Make sure this episode is on your pre-conference checklist!

In the latest episode of Lung Cancer Considered, Dr. Stephen Liu and Dr. Narjust Florez share practical tips to help you make the most of your WCLC 2026 experience, from preparing for the flight and beating jet lag to navigating COEX, networking, exploring Seoul’s food scene, and more.

🎧 Listen before you go: https://bit.ly/4gyCqrI

09/03/2026

WCLC is almost here! 🌎

If you can’t make it to Seoul, you don’t have to miss the latest science and conversations shaping thoracic oncology.

Join WCLC virtually September 12–15 for livestreamed scientific sessions, recordings, presentation slides, abstracts and posters.

💻 Register for virtual access: https://bit.ly/4zRPcct

09/03/2026

How is the management of oligometastatic lung cancer evolving?

In the newest episode of Lung Cancer Considered, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to discuss key definitions, patient selection, and the role of consolidative therapies such as radiation and surgery.

They also explore how emerging tools like ctDNA may help shape a more precise approach to care.

🎧 Listen to the full conversation: https://bit.ly/45UywTZ

09/01/2026

Applications are now open for two IASLC career development opportunities!

🎓 2027 IASLC Academy: Early-career physicians can build their skills through mentorship, education, networking and the development of a personal research project.

🔬 IASLC Career Advancement Grant: Mid-career professionals can apply for a $100,000, one-year grant to support research focused on lung cancer and thoracic malignancies.

At every stage of your career, the right opportunity can help you take the next step. Explore these IASLC programs and find the opportunity that fits where you are in your career.

Learn more:
IASLC Academy: https://bit.ly/4xxB5Yk
Career Advancement Grant: https://bit.ly/4wZx0eg

08/31/2026

Have research to share? There’s still time to submit an abstract for ! 🔬

Join colleagues from across North America and beyond December 4–6 in Scottsdale, Arizona, and share your latest work with the thoracic oncology community.

Selected oral presentations receive travel support and complimentary registration, with Education Awards also available for top-rated posters.

⏰ Abstracts are due September 28.

Submit your abstract: https://bit.ly/46xfHGu

08/30/2026

🏆 Challenge accepted: Move, connect, and win prizes at by participating in the IASLC Wellness Challenge.

Learn more in ILCN:

Turn your steps and other wellness activities into points at WCLC 2026 by participating in the IASLC Wellness Challenge.

08/30/2026

While the NRG/Alliance LU005 trial did not yield a survival benefit, Dr. Adam Schoenfeld says the study strengthens the case that sequencing matters with regard to immunotherapy timing.

🔗 Learn more in ILCN:

While the trial did not yield a survival benefit, Dr. Adam Schoenfeld says the study strengthens the case that immunotherapy timing and sequencing matter.

08/28/2026

🎙️ Listen to the newest Korean-language episode of Lung Cancer Considered.

Dr. Chul Kim, Dr. Hye Ryun Kim, and Dr. Young Kwang Chae discuss the evolving role of immunotherapy in lung cancer, including perioperative strategies for resectable NSCLC, biomarkers and treatment selection in advanced disease, and emerging research.

They also share what they’re looking forward to at WCLC 2026 in Seoul. 🇰🇷

🎧 Listen now: https://bit.ly/4gvJHHw

08/27/2026

Patient advocacy has helped transform the lung cancer landscape over the past 20 years. What progress has been made, and where is there still work to do?

Professor Jean-Louis Pujol joins Dr. Alex Adjei and Dr. Tom John on JTO Insights to reflect on the evolution of lung cancer patient advocacy and the challenges ahead.

🎧 Listen to the conversation: https://bit.ly/4hUhwEt

Université de Montpellier

Two decades have brought significant progress in lung cancer patient advocacy, but new challenges continue to emerge.

In the latest JTO Insights episode, Dr. Alex Adjei and Dr. Tom John welcome Professor Jean-Louis Pujol to discuss “Lung cancer patient advocacy progress and new challenges since 2006,” featured in the JTO 20th Anniversary Series.

🎧 Listen here: https://bit.ly/4hUhwEt

Université de Montpellier